Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1998
02/17/1998US5719123 Administering crystal form
02/17/1998US5719122 Enhancing transdermal or transmucosal absorption by administering with a saturated polyglycolysed glyceride
02/17/1998US5719121 Administering balhimycin to monogastric or polygastric animal as growth promoter
02/17/1998US5719120 Use of endoglin polypeptides for modifying the regulatory activity of TGF-β
02/17/1998US5719064 Autoimmune diseases
02/17/1998US5719057 Genetic engineering
02/17/1998US5719055 Insertion of dna into host gene; genetic engineering
02/17/1998US5719044 Complexing
02/17/1998US5719042 Nucleic acids encoding transcription factor APRF (acute phase response factor)
02/17/1998US5719041 DNA encoding ecotin homologs
02/17/1998US5719032 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
02/17/1998US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme
02/17/1998US5718900 Vaccines and methods for preventing and treating Fescue toxicosis in herbivores
02/17/1998US5718899 High concentration of immunoglobulins
02/17/1998US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase
02/17/1998US5718896 Contacting fluids with composition containing a haloperoxidase, a semen substrate-specific oxidase and a carrier
02/17/1998US5718893 Use of G-CSF to reduce acute rejection
02/17/1998US5718882 IKVAV peptide radiopharmaceutical applications
02/17/1998CA1339679C Reduced size lhrh analogs
02/17/1998CA1339678C Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease
02/13/1998CA2212786A1 Novel glutamine:fructose-6-phosphate amidotransferase, its production and use
02/12/1998WO1998005968A1 Brca1 associated protein (bap-1) and uses therefor
02/12/1998WO1998005792A2 A novel human leptin receptor gene-related protein
02/12/1998WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
02/12/1998WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
02/12/1998WO1998005783A1 A tumor necrosis factor related ligand
02/12/1998WO1998005782A1 Testis-specific insulin homolog polypeptides
02/12/1998WO1998005781A1 Secreted proteins and polynucleotides encoding them
02/12/1998WO1998005780A2 Voltage-gated calcium channel antagonist and methods
02/12/1998WO1998005779A1 Modified tie-2-receptor ligands
02/12/1998WO1998005777A2 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO
02/12/1998WO1998005776A2 Secreted proteins and polynucleotides encoding them
02/12/1998WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application
02/12/1998WO1998005774A1 Use of a human vascular endothelial cell growth factor gene for direct genetic therapy
02/12/1998WO1998005772A1 Ectoparasite histamine releasing factor, genes and uses thereof
02/12/1998WO1998005770A2 Antisense rna with a secondary structure
02/12/1998WO1998005769A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
02/12/1998WO1998005768A1 Improved nucleic acids encoding a chimeric glycosyltransferase
02/12/1998WO1998005762A1 Plasminogen activator capable of being activated by thrombin
02/12/1998WO1998005755A1 Detection, prevention and treatment of papillomatous digital dermatitis
02/12/1998WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
02/12/1998WO1998005685A2 Self-aligning peptides derived from elastin and other fibrous proteins
02/12/1998WO1998005684A2 Mhc binding peptide oligomers and methods of use
02/12/1998WO1998005683A1 Parathyroid hormone analogues for the treatment of osteoporosis
02/12/1998WO1998005673A1 Methods for purifying nucleic acids
02/12/1998WO1998005363A2 Polypeptides having a single covalently bound n-terminal water-soluble polymer
02/12/1998WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them
02/12/1998WO1998005358A1 Sustained release preparations for injection containing gabexate mesylate
02/12/1998WO1998005357A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
02/12/1998WO1998005354A2 Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors
02/12/1998WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
02/12/1998WO1998005352A1 Hypothalamus-specific polypeptides
02/12/1998WO1998005351A1 Methods for regulating gastrointestinal motility
02/12/1998WO1998005350A1 Materials and methods for treatment of plaquing diseases
02/12/1998WO1998005349A1 A novel method of detecting and treating cancer
02/12/1998WO1998005348A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
02/12/1998WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
02/12/1998WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
02/12/1998WO1998005331A2 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
02/12/1998WO1998005309A1 Cyclosporin formulation
02/12/1998WO1998005307A1 Transmural drug delivery method and apparatus
02/12/1998WO1998005221A1 Drinkable, acid nutrient composition with long shelf life and health-promoting action
02/12/1998WO1998000183A3 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
02/12/1998WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation
02/12/1998WO1997045139A3 Il-12 as an adjuvant for bordetella pertussis vaccines
02/12/1998WO1997044354A3 Synthesis of soluble beta-sheet forming peptides
02/12/1998WO1997043414A3 A basal cell carcinoma tumor suppressor gene
02/12/1998WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses
02/12/1998DE19631919A1 Anti-Sinn-RNA mit Sekundärstruktur Anti-sense RNA secondary structure
02/12/1998DE19629095A1 Verwendung von rekombinantem Myelinprotein zur Behandlung von T-Zell vermittelten Autoimmunerkrankungen des peripheren Nervensystems Use of recombinant myelin protein for the treatment of T-cell mediated autoimmune disorders of the peripheral nervous system
02/12/1998CA2791778A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
02/12/1998CA2262994A1 Polypeptides having a single covalently bound n-terminal water-soluble polymer
02/12/1998CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
02/12/1998CA2262753A1 Voltage-gated calcium channel antagonist and methods
02/12/1998CA2262751A1 Plasminogen activator capable of being activated by thrombin
02/12/1998CA2262696A1 Bcl-xy, a novel bcl-x isoform, and uses related thereto
02/12/1998CA2262624A1 A novel method of detecting and treating cancer
02/12/1998CA2262479A1 Brca1 associated protein (bap-1) and uses therefor
02/12/1998CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application
02/12/1998CA2262446A1 Self-aligning peptides derived from elastin and other fibrous proteins
02/12/1998CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
02/12/1998CA2262405A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
02/12/1998CA2262401A1 Secreted proteins and polynucleotides encoding them
02/12/1998CA2262399A1 Secreted proteins and polynucleotides encoding them
02/12/1998CA2261573A1 A novel human leptin receptor gene-related protein
02/12/1998CA2261565A1 Hypothalamus-specific polypeptides
02/12/1998CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
02/12/1998CA2233987A1 Materials and methods for treatment of plaquing diseases
02/12/1998CA2233705A1 Improved nucleic acids encoding a chimeric glycosyltransferase
02/12/1998CA2233570A1 Detection, prevention and treatment of papillomatous digital dermatitis
02/11/1998EP0823478A2 Human cartilage gp 39-like gene
02/11/1998EP0823476A2 Method for activating prothrombin to thrombin
02/11/1998EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods
02/11/1998EP0823257A1 Medicinal composition for curing thrombocytopenia
02/11/1998EP0823256A1 Preventive and/or remedy for ischemic diseases
02/11/1998EP0822991A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
02/11/1998EP0822988A2 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
02/11/1998EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus
02/11/1998EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
02/11/1998EP0822985A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes